Fingerprint
Dive into the research topics of 'Corrigendum to “Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer” [Gynecologic Oncology Volume 161, Issue 3, June 2021, Pages 676-680] (Gynecologic Oncology (2021) 161(3) (676–680), (S0090825821002298), (10.1016/j.ygyno.2021.03.009))'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically